2,2'-(2-Vinylanthracene-9,10-diylidene)dimalononitrile, 98% mix TBC as stabilizer, 200mg

2-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]-4'-methoxy benzophenone, 97.0%, 1g

N-(9-((2R,4S,5R)-4-Hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-9H-purin-6-yl)benzamide, 95.0%, 10g

HPLC column NUCLEODUR® 100-3 C18 ec 3 µm, 250 mm, 4.6 mm, 1 Piece(s)

tert-Butyl but-3-enoate, 95%, 25g

3',6'-Dihydroxy-3-oxo-3H-spiro[isobenzofuran-1,9'-xanthene]-5-carboxylic acid, 95.0%, 1g

1-Benzyl-3-methylpyrrolidin-3-ol, 95.0%, 10g

N3-Benzylpyridine-3,4-diamine, 95.0%, 1g

2-(1,3-Benzoxazol-2-yl)-1-[4-(trifluoromethyl)phenyl]ethanone, 97.0%, 5g

6,7-Dihydro-5H-pyrrolo[1,2-a]imidazole-6-carboxylic acid hydrochloride, 97.0%, 1g

L-Trypthophane(Boc) N-carboxyanhydride, 5mg

10H-phenoxazine, 98.0%, 1g

7H-Pyrrolo[2,3-d]pyriMidine, 4-chloro-5-iodo-7-(2,3,5-tri-O-benzoyl-?-D-ribofuranosyl)-, 97%, 100mg